Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

Cronos Group

If you think dilution is no big deal, then you're flat-out wrong.

Share-Based Dilution Has Crushed Pot Stock Returns

GW Pharmaceuticals

Scotts Miracle-Gro

Several CBD manufacturers, researchers, farmers and retailers have urged the regulatory authority to allow the use of cannabis.

FDA to Hold First Public Hearing on Cannabis: 5 Likely Gainers

"That's just enough time to use all of our IP and brands to really get ahead," Canopy Growth CEO Bruce Linton says about its acquisition of Acreage.

Canopy expects to see the next cannabis breakthrough in 24 months

Canopy Growth Corporation (CGC) closed at $42.23 in the latest trading session, marking a -0.59% move from the prior day.

Canopy Growth Corporation Stock Sinks As Market Gains

This under-the-radar marijuana stock is targeting 131,300 kilos in run-rate production by August, and over 479,000 kilos annually in the future.

A Completely Unknown Pot Stock Aims to Be Canada's Third-Largest Cannabis Grower

CVS Health

There's a lot at stake with a key public hearing later this week that's intended to help the FDA establish regulations for the U.S. hemp CBD industry.

What to Expect From the FDA's CBD Hearing

CGC stock is likely to face volatility and price weakness in June. Here are the pros and cons to Canopy Growth right now.

Should You Buy Canopy Growth Stock Prior to Earnings in June?

Tilray Brands

There are plenty of marijuana stocks to buy these days. However, these three could be the only ones really worth it for the long haul.

The Only 3 Marijuana Stocks You Need to Own

The trade war is obviously terrible news for most sectors, but CGC stock and the marijuana industry should enjoy a tailwind of political and economic necessity.

The Trade War Could Be Good News for CGC Stock

Acreage Holdings, Inc. (OTC: ACRGF) said in its first-quarter report Tuesday that its revenue grew substantially despite regulatory delays in the opening of dispensaries.

Acreage Holdings Reports 487% Year-Over-Year Jump In Revenue, Says Canopy Growth Deal Will Accelerate Growth

CGC stock, like other marijuana stocks, is viewed as a growth play and the cannabis market is still in its early innings of growth. But the longer term outlook of Canopy stock looks bright.

Canopy Growth Stock Is an Intriguing Cannabis Name

The Canadian marijuana producer's recent small deal could be a bigger deal over the long run.

3 Things to Really Like About Canopy Growth's Latest Acquisition

Constellation Brands

The beverage giant's $4 billion bet on Canopy Growth is only the first step in building a leading global alcohol and cannabis enterprise.

How Constellation Brands Could Become The Global Pot King

Vert Mirabel, the subsidiary of Canopy Growth Corporation and a portfolio company of Canopy Rivers Inc. announced it received the last needed cultivation license from Health Canada to approve all 700,000 square feet of its cannabis production facility in Mirabel, Quebec.

Canopy Subsidiary Vert Mirabel Now Fully Licensed By Health Canada

Acreage Holdings Inc. said Tuesday that shareholders that hold about 91% of the votes eligible to be cast at a special meeting on June 19 favor Canopy Growth Corp. proposed takeover of the company, as soon as cannabis has been legalized in the U.S.

Acreage Holdings says shareholders with 91% of vote favor deal with Canopy Growth

Aphria

HEXO Corp

Three candidates appear to be at the top of the list.

Which Smaller Marijuana Stock Is Most Likely to Join Aurora Cannabis and Canopy Growth at the Top?

America's most popular professional sport plans to research the medical buzz surrounding pot.

Hut. Hut. High! The NFL to Consider Marijuana as a Possible Pain Management Tool

There's something the surveys don't reveal.

Don't Expect Quick U.S. Marijuana Legalization Based on Polls Showing Support: There's a Big Gotcha

Canopy Growth Corporation (CGC) closed the most recent trading day at $44.42, moving -0.31% from the previous trading session.

CGC: Stock Sinks As Market Gains

Canopy Growth rose 1% as investors in the cannabis company reviewed and analyzed information circulars released yesterday related to its proposed collaboration with Acreage Holdings.

Canopy, Acreage go to shareholders

Can Canopy Growth stock continue its recent run higher? CGC stock is breaking out over resistance, but now needs to maintain momentum.

Canopy Growth Stock Could Regain Its 2019 Highs

CannTrust Holdings

Greenlane Holdings

Innovative Industrial Properties

Nasdaq

Village Farms International

Nearly a dozen marijuana stocks are now listed side by side with time-tested businesses on reputable U.S. exchanges.

11 Pot Stocks Now Listed on the NYSE or Nasdaq

Zynerba Pharmaceuticals

The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.

7 Marijuana Stocks to Play the CBD Trend

Martha Stuart's investment in Canopy Growth stock grabs headlines but does it mean you should follow the trade?
The post There’s No Question Canopy Growth Stock Wins in the Long Term appeared first on InvestorPlace.

There’s No Question Canopy Growth Stock Wins in the Long Term

It's not a great reason in and of itself to buy CGC stock, but Canopy Growth does have an overlooked presence in the medical cannabis arena.

News for Canopy Growth Stock (CGC)